 | • レポートコード：D0GIR-08712 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ガバペンチンエナカルビルの世界市場を広く調査・分析し、今後の市場展望をまとめております。ガバペンチンエナカルビルの種類別市場規模（カプセル、タブレット）、用途別市場規模（帯状疱疹後神経痛（PHN）、むずむず脚症候群（RLS）、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Arbor Pharma、Mylan、Glenmark Pharma、Astellas、Teva、GlaxoSmithKline、Apotex、Depomed、Pfizer、Novartis、Marksans Pharma、Jiangsu Hengrui、Sun Pharmaceutical、Alkem、Amneal、Aurobindo Pharma、Sailike Pharma、Jiangsu Enhua、Intas ・地域別グローバル市場分析 2015年-2020年 ・ガバペンチンエナカルビルの北米市場（アメリカ、カナダ、メキシコ） ・ガバペンチンエナカルビルのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ガバペンチンエナカルビルのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ガバペンチンエナカルビルの南米市場（ブラジル、アルゼンチン） ・ガバペンチンエナカルビルの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：カプセル、タブレット ・用途別分析：帯状疱疹後神経痛（PHN）、むずむず脚症候群（RLS）、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Gabapentin Enacarbil market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Gabapentin Enacarbil market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of XX%% in the forecast period of 2020 to 2025 and will expected to reach USD XX million by 2025, from USD XX million in 2019.
Market segmentation
Gabapentin Enacarbil market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gabapentin Enacarbil market has been segmented into
Capsule
Tablet
By Application, Gabapentin Enacarbil has been segmented into:
Post-Herpetic Neuralgia (PHN)
Restless Legs Syndrome (RLS)
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gabapentin Enacarbil market presented in the report. This section sheds light on the sales growth of different regional and country-level Gabapentin Enacarbil markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gabapentin Enacarbil market.
The report offers in-depth assessment of the growth and other aspects of the Gabapentin Enacarbil market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gabapentin Enacarbil Market Share Analysis
Gabapentin Enacarbil competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gabapentin Enacarbil sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gabapentin Enacarbil sales, revenue and market share for each player covered in this report.
The major players covered in Gabapentin Enacarbil are:
Arbor Pharma
Mylan
Glenmark Pharma
Astellas
Teva
GlaxoSmithKline
Apotex
Depomed
Pfizer
Novartis
Marksans Pharma
Jiangsu Hengrui
Sun Pharmaceutical
Alkem
Amneal
Aurobindo Pharma
Sailike Pharma
Jiangsu Enhua
Intas
Among other players domestic and global, Gabapentin Enacarbil market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gabapentin Enacarbil product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gabapentin Enacarbil, with price, sales, revenue and global market share of Gabapentin Enacarbil in 2018 and 2019.
Chapter 3, the Gabapentin Enacarbil competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gabapentin Enacarbil breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gabapentin Enacarbil market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gabapentin Enacarbil sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gabapentin Enacarbil Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gabapentin Enacarbil Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Capsule
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Gabapentin Enacarbil Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Post-Herpetic Neuralgia (PHN)
1.3.3 Restless Legs Syndrome (RLS)
1.3.4 Others
1.4 Overview of Global Gabapentin Enacarbil Market
1.4.1 Global Gabapentin Enacarbil Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Arbor Pharma
2.1.1 Arbor Pharma Details
2.1.2 Arbor Pharma Major Business
2.1.3 Arbor Pharma SWOT Analysis
2.1.4 Arbor Pharma Product and Services
2.1.5 Arbor Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Glenmark Pharma
2.3.1 Glenmark Pharma Details
2.3.2 Glenmark Pharma Major Business
2.3.3 Glenmark Pharma SWOT Analysis
2.3.4 Glenmark Pharma Product and Services
2.3.5 Glenmark Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Astellas
2.4.1 Astellas Details
2.4.2 Astellas Major Business
2.4.3 Astellas SWOT Analysis
2.4.4 Astellas Product and Services
2.4.5 Astellas Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business
2.5.3 Teva SWOT Analysis
2.5.4 Teva Product and Services
2.5.5 Teva Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Product and Services
2.6.4 GlaxoSmithKline Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Apotex
2.7.1 Apotex Details
2.7.2 Apotex Major Business
2.7.3 Apotex Product and Services
2.7.4 Apotex Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Depomed
2.8.1 Depomed Details
2.8.2 Depomed Major Business
2.8.3 Depomed Product and Services
2.8.4 Depomed Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Product and Services
2.9.4 Pfizer Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Product and Services
2.10.4 Novartis Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Marksans Pharma
2.11.1 Marksans Pharma Details
2.11.2 Marksans Pharma Major Business
2.11.3 Marksans Pharma Product and Services
2.11.4 Marksans Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Jiangsu Hengrui
2.12.1 Jiangsu Hengrui Details
2.12.2 Jiangsu Hengrui Major Business
2.12.3 Jiangsu Hengrui Product and Services
2.12.4 Jiangsu Hengrui Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sun Pharmaceutical
2.13.1 Sun Pharmaceutical Details
2.13.2 Sun Pharmaceutical Major Business
2.13.3 Sun Pharmaceutical Product and Services
2.13.4 Sun Pharmaceutical Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Alkem
2.14.1 Alkem Details
2.14.2 Alkem Major Business
2.14.3 Alkem Product and Services
2.14.4 Alkem Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Amneal
2.15.1 Amneal Details
2.15.2 Amneal Major Business
2.15.3 Amneal Product and Services
2.15.4 Amneal Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Aurobindo Pharma
2.16.1 Aurobindo Pharma Details
2.16.2 Aurobindo Pharma Major Business
2.16.3 Aurobindo Pharma Product and Services
2.16.4 Aurobindo Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Sailike Pharma
2.17.1 Sailike Pharma Details
2.17.2 Sailike Pharma Major Business
2.17.3 Sailike Pharma Product and Services
2.17.4 Sailike Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Jiangsu Enhua
2.18.1 Jiangsu Enhua Details
2.18.2 Jiangsu Enhua Major Business
2.18.3 Jiangsu Enhua Product and Services
2.18.4 Jiangsu Enhua Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Intas
2.19.1 Intas Details
2.19.2 Intas Major Business
2.19.3 Intas Product and Services
2.19.4 Intas Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gabapentin Enacarbil Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gabapentin Enacarbil Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gabapentin Enacarbil Manufacturer Market Share in 2019
3.3.2 Top 6 Gabapentin Enacarbil Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gabapentin Enacarbil Sales, Revenue and Market Share by Regions
4.1.1 Global Gabapentin Enacarbil Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gabapentin Enacarbil Revenue and Market Share by Regions (2015-2020)
4.2 North America Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
4.3 Europe Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
4.5 South America Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gabapentin Enacarbil Sales, Revenue and Market Share by Country
5.1.1 North America Gabapentin Enacarbil Sales and Market Share by Country (2015-2020)
5.1.2 North America Gabapentin Enacarbil Revenue and Market Share by Country (2015-2020)
5.2 United States Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
5.3 Canada Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
5.4 Mexico Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gabapentin Enacarbil Sales, Revenue and Market Share by Country
6.1.1 Europe Gabapentin Enacarbil Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gabapentin Enacarbil Revenue and Market Share by Country (2015-2020)
6.2 Germany Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
6.3 UK Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
6.4 France Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
6.5 Russia Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
6.6 Italy Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gabapentin Enacarbil Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gabapentin Enacarbil Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gabapentin Enacarbil Revenue and Market Share by Regions (2015-2020)
7.2 China Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
7.3 Japan Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
7.4 Korea Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
7.5 India Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
7.7 Australia Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gabapentin Enacarbil Sales, Revenue and Market Share by Country
8.1.1 South America Gabapentin Enacarbil Sales and Market Share by Country (2015-2020)
8.1.2 South America Gabapentin Enacarbil Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
8.3 Argentina Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gabapentin Enacarbil Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gabapentin Enacarbil Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gabapentin Enacarbil Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
9.3 Turkey Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
9.4 Egypt Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
9.5 South Africa Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gabapentin Enacarbil Sales and Market Share by Type (2015-2020)
10.2 Global Gabapentin Enacarbil Revenue and Market Share by Type (2015-2020)
10.3 Global Gabapentin Enacarbil Price by Type (2015-2020)
11 Global Gabapentin Enacarbil Market Segment by Application
11.1 Global Gabapentin Enacarbil Sales Market Share by Application (2015-2020)
11.2 Global Gabapentin Enacarbil Revenue Market Share by Application (2015-2020)
11.3 Global Gabapentin Enacarbil Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gabapentin Enacarbil Sales, Revenue and Growth Rate (2021-2025)
12.2 Gabapentin Enacarbil Market Forecast by Regions (2021-2025)
12.2.1 North America Gabapentin Enacarbil Market Forecast (2021-2025)
12.2.2 Europe Gabapentin Enacarbil Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gabapentin Enacarbil Market Forecast (2021-2025)
12.2.4 South America Gabapentin Enacarbil Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gabapentin Enacarbil Market Forecast (2021-2025)
12.3 Gabapentin Enacarbil Market Forecast by Type (2021-2025)
12.3.1 Global Gabapentin Enacarbil Sales Forecast by Type (2021-2025)
12.3.2 Global Gabapentin Enacarbil Market Share Forecast by Type (2021-2025)
12.4 Gabapentin Enacarbil Market Forecast by Application (2021-2025)
12.4.1 Global Gabapentin Enacarbil Sales Forecast by Application (2021-2025)
12.4.2 Global Gabapentin Enacarbil Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gabapentin Enacarbil Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gabapentin Enacarbil by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gabapentin Enacarbil Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Gabapentin Enacarbil Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Arbor Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Arbor Pharma Gabapentin Enacarbil Major Business
Table 10. Arbor Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 11. Arbor Pharma SWOT Analysis
Table 12. Arbor Pharma Gabapentin Enacarbil Product and Services
Table 13. Arbor Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Mylan Basic Information, Manufacturing Base and Competitors
Table 15. Mylan Gabapentin Enacarbil Major Business
Table 16. Mylan Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 17. Mylan SWOT Analysis
Table 18. Mylan Gabapentin Enacarbil Product and Services
Table 19. Mylan Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Glenmark Pharma Basic Information, Manufacturing Base and Competitors
Table 21. Glenmark Pharma Gabapentin Enacarbil Major Business
Table 22. Glenmark Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 23. Glenmark Pharma SWOT Analysis
Table 24. Glenmark Pharma Gabapentin Enacarbil Product and Services
Table 25. Glenmark Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Astellas Basic Information, Manufacturing Base and Competitors
Table 27. Astellas Gabapentin Enacarbil Major Business
Table 28. Astellas Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 29. Astellas SWOT Analysis
Table 30. Astellas Gabapentin Enacarbil Product and Services
Table 31. Astellas Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Teva Basic Information, Manufacturing Base and Competitors
Table 33. Teva Gabapentin Enacarbil Major Business
Table 34. Teva Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 35. Teva SWOT Analysis
Table 36. Teva Gabapentin Enacarbil Product and Services
Table 37. Teva Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Gabapentin Enacarbil Major Business
Table 40. GlaxoSmithKline Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 41. GlaxoSmithKline SWOT Analysis
Table 42. GlaxoSmithKline Gabapentin Enacarbil Product and Services
Table 43. GlaxoSmithKline Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Apotex Basic Information, Manufacturing Base and Competitors
Table 45. Apotex Gabapentin Enacarbil Major Business
Table 46. Apotex Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 47. Apotex SWOT Analysis
Table 48. Apotex Gabapentin Enacarbil Product and Services
Table 49. Apotex Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Depomed Basic Information, Manufacturing Base and Competitors
Table 51. Depomed Gabapentin Enacarbil Major Business
Table 52. Depomed Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 53. Depomed SWOT Analysis
Table 54. Depomed Gabapentin Enacarbil Product and Services
Table 55. Depomed Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Pfizer Basic Information, Manufacturing Base and Competitors
Table 57. Pfizer Gabapentin Enacarbil Major Business
Table 58. Pfizer Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 59. Pfizer SWOT Analysis
Table 60. Pfizer Gabapentin Enacarbil Product and Services
Table 61. Pfizer Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Novartis Basic Information, Manufacturing Base and Competitors
Table 63. Novartis Gabapentin Enacarbil Major Business
Table 64. Novartis Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 65. Novartis SWOT Analysis
Table 66. Novartis Gabapentin Enacarbil Product and Services
Table 67. Novartis Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Marksans Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Marksans Pharma Gabapentin Enacarbil Major Business
Table 70. Marksans Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 71. Marksans Pharma SWOT Analysis
Table 72. Marksans Pharma Gabapentin Enacarbil Product and Services
Table 73. Marksans Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 75. Jiangsu Hengrui Gabapentin Enacarbil Major Business
Table 76. Jiangsu Hengrui Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 77. Jiangsu Hengrui SWOT Analysis
Table 78. Jiangsu Hengrui Gabapentin Enacarbil Product and Services
Table 79. Jiangsu Hengrui Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 81. Sun Pharmaceutical Gabapentin Enacarbil Major Business
Table 82. Sun Pharmaceutical Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 83. Sun Pharmaceutical SWOT Analysis
Table 84. Sun Pharmaceutical Gabapentin Enacarbil Product and Services
Table 85. Sun Pharmaceutical Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Alkem Basic Information, Manufacturing Base and Competitors
Table 87. Alkem Gabapentin Enacarbil Major Business
Table 88. Alkem Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 89. Alkem SWOT Analysis
Table 90. Alkem Gabapentin Enacarbil Product and Services
Table 91. Alkem Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Amneal Basic Information, Manufacturing Base and Competitors
Table 93. Amneal Gabapentin Enacarbil Major Business
Table 94. Amneal Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 95. Amneal SWOT Analysis
Table 96. Amneal Gabapentin Enacarbil Product and Services
Table 97. Amneal Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 99. Aurobindo Pharma Gabapentin Enacarbil Major Business
Table 100. Aurobindo Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 101. Aurobindo Pharma SWOT Analysis
Table 102. Aurobindo Pharma Gabapentin Enacarbil Product and Services
Table 103. Aurobindo Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Sailike Pharma Basic Information, Manufacturing Base and Competitors
Table 105. Sailike Pharma Gabapentin Enacarbil Major Business
Table 106. Sailike Pharma Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 107. Sailike Pharma SWOT Analysis
Table 108. Sailike Pharma Gabapentin Enacarbil Product and Services
Table 109. Sailike Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Jiangsu Enhua Gabapentin Enacarbil Type and Application
Table 111. Jiangsu Enhua Gabapentin Enacarbil Major Business
Table 112. Jiangsu Enhua Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 113. Jiangsu Enhua SWOT Analysis
Table 114. Jiangsu Enhua Gabapentin Enacarbil Product and Services
Table 115. Jiangsu Enhua Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 116. Intas Basic Information, Manufacturing Base and Competitors
Table 117. Intas Gabapentin Enacarbil Major Business
Table 118. Intas Gabapentin Enacarbil Total Revenue (USD Million) (2018-2019)
Table 119. Intas SWOT Analysis
Table 120. Intas Gabapentin Enacarbil Product and Services
Table 121. Intas Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 122. Global Gabapentin Enacarbil Sales by Manufacturer (2018-2019) (K Units)
Table 123. Global Gabapentin Enacarbil Revenue by Manufacturer (2018-2019) (USD Million)
Table 124. Global Gabapentin Enacarbil Sales by Regions (2015-2020) (K Units)
Table 125. Global Gabapentin Enacarbil Sales Market Share by Regions (2015-2020)
Table 126. Global Gabapentin Enacarbil Revenue by Regions (2015-2020) (USD Million)
Table 127. North America Gabapentin Enacarbil Sales by Countries (2015-2020) (K Units)
Table 128. North America Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Table 129. North America Gabapentin Enacarbil Revenue by Countries (2015-2020) (USD Million)
Table 130. North America Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Table 131. Europe Gabapentin Enacarbil Sales by Countries (2015-2020) (K Units)
Table 132. Europe Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Table 133. Europe Gabapentin Enacarbil Revenue by Countries (2015-2020) (USD Million)
Table 134. Asia-Pacific Gabapentin Enacarbil Sales by Regions (2015-2020) (K Units)
Table 135. Asia-Pacific Gabapentin Enacarbil Sales Market Share by Regions (2015-2020)
Table 136. Asia-Pacific Gabapentin Enacarbil Revenue by Regions (2015-2020) (USD Million)
Table 137. South America Gabapentin Enacarbil Sales by Countries (2015-2020) (K Units)
Table 138. South America Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Table 139. South America Gabapentin Enacarbil Revenue by Countries (2015-2020) (USD Million)
Table 140. South America Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Table 141. Middle East & Africa Gabapentin Enacarbil Sales by Countries (2015-2020) (K Units)
Table 142. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Table 143. Middle East & Africa Gabapentin Enacarbil Revenue by Countries (2015-2020) (USD Million)
Table 144. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Table 145. Global Gabapentin Enacarbil Sales by Type (2015-2020) (K Units)
Table 146. Global Gabapentin Enacarbil Sales Share by Type (2015-2020)
Table 147. Global Gabapentin Enacarbil Revenue by Type (2015-2020) (USD Million)
Table 148. Global Gabapentin Enacarbil Revenue Share by Type (2015-2020)
Table 149. Global Gabapentin Enacarbil Sales by Application (2015-2020) (K Units)
Table 150. Global Gabapentin Enacarbil Sales Share by Application (2015-2020)
Table 151. Global Gabapentin Enacarbil Sales Forecast by Regions (2021-2025) (K Units)
Table 152. Global Gabapentin Enacarbil Market Share Forecast by Regions (2021-2025)
Table 153. Global Gabapentin Enacarbil Sales Forecast by Type (2021-2025) (K Units)
Table 154. Global Gabapentin Enacarbil Market Share Forecast by Type (2021-2025)
Table 155. Global Gabapentin Enacarbil Sales Forecast by Application (2021-2025)
Table 156. Global Gabapentin Enacarbil Market Share Forecast by Application (2021-2025)
Table 157. Direct Channel Pros & Cons
Table 158. Indirect Channel Pros & Cons
Table 159. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gabapentin Enacarbil Picture
Figure 2. Global Sales Market Share of Gabapentin Enacarbil by Type in 2019
Figure 3. Capsule Picture
Figure 4. Tablet Picture
Figure 5. Gabapentin Enacarbil Sales Market Share by Application in 2019
Figure 6. Post-Herpetic Neuralgia (PHN) Picture
Figure 7. Restless Legs Syndrome (RLS) Picture
Figure 8. Others Picture
Figure 9. Global Gabapentin Enacarbil Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Gabapentin Enacarbil Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Gabapentin Enacarbil Sales Market Share by Manufacturer in 2019
Figure 30. Global Gabapentin Enacarbil Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Gabapentin Enacarbil Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Gabapentin Enacarbil Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Gabapentin Enacarbil Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Gabapentin Enacarbil Revenue Market Share by Regions (2015-2020)
Figure 37. Global Gabapentin Enacarbil Revenue Market Share by Regions in 2018
Figure 38. North America Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
Figure 39. Europe Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
Figure 41. South America Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Gabapentin Enacarbil Sales and Growth Rate (2015-2020)
Figure 43. North America Gabapentin Enacarbil Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Gabapentin Enacarbil Sales Market Share by Countries (2015-2020)
Figure 45. North America Gabapentin Enacarbil Sales Market Share by Countries in 2018
Figure 46. North America Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Gabapentin Enacarbil Revenue Market Share by Countries in 2018
Figure 48. United States Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Gabapentin Enacarbil Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Gabapentin Enacarbil Revenue Market Share by Countries in 2019
Figure 54. Germany Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Gabapentin Enacarbil Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Gabapentin Enacarbil Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Gabapentin Enacarbil Revenue Market Share by Regions 2019
Figure 62. China Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Gabapentin Enacarbil Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Gabapentin Enacarbil Sales Market Share by Countries in 2019
Figure 69. South America Gabapentin Enacarbil Revenue Market Share by Countries in 2019
Figure 70. Brazil Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Gabapentin Enacarbil Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Gabapentin Enacarbil Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Gabapentin Enacarbil Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Gabapentin Enacarbil Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Gabapentin Enacarbil Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Gabapentin Enacarbil Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Gabapentin Enacarbil Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Gabapentin Enacarbil Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Gabapentin Enacarbil Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Gabapentin Enacarbil Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Gabapentin Enacarbil Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Gabapentin Enacarbil Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
周期性発熱症候群の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Periodic Fever Syndrome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Periodic Fever Syndro…- ポストエッチ残渣除去剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Post Etch Residue Remover market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- チャーグ・ストラウス症候群の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Churg Strauss Syndrome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Churg Strauss Syndrome…
- エッチング残留物（PER）クリーナーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Post Etch Residue (PER) Cleaners market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- エベロリムス錠の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Everolimus Tablet market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Everolimus Tablet market re…